Modern Analytics & AI in Life Sciences Conference | Rev 2026 Philadelphia

Pharma, biotech, and CRO organizations are under pressure to modernize analytics and AI while maintaining compliance, reproducibility, and inspection readiness. Leaders are moving beyond siloed tools and one-off initiatives to build consistent, governed environments that support both statistical programming and advanced AI.

Leaders from Bristol Myers Squibb, UCB, AstraZeneca, Merck, and more will share how they are:

-Scaling AI from experimentation to enterprise-wide execution
-Modernizing statistical computing to improve quality and audibility
-Strengthening inspection readiness while reducing operational risk
-Using governance to enable innovation rather than slow it down
-Exploring emerging AI capabilities within clear, compliant guardrails

Rev 2026 is Domino Data Lab’s premier event series for enterprise AI, Data Science, and IT leaders. This year’s theme, “Lead with Impact,” addresses how organizations can move beyond isolated AI pilots to build governed, reliable, and scalable systems that drive measurable business results.